Chemomab Therapeutics Ltd CMMB:NASDAQ

Last Price$3.32NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change0(0.00%)
Bid (Size)$3.26 (1)
Ask (Size)$3.98 (4)
Day Low / HighN/A - N/A
Volume36.5 K
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

Chemomab Therapeutics Ltd ( NASDAQ )

Price: $3.32
Change: -0.38 (10.27%)
Volume: 36.5 K
4:00PM ET 7/01/2022
 
 

Larimar Therapeutics Inc ( NASDAQ )

Price: $2.15
Change: +0.19 (9.69%)
Volume: 46.0 K
4:00PM ET 7/01/2022
 
 

Microbot Medical Inc ( NASDAQ )

Price: $5.01
Change: -0.12 (2.34%)
Volume: 5.5 K
4:00PM ET 7/01/2022
 
 

AVROBIO Inc ( NASDAQ )

Price: $0.92
Change: +0.0001 (0.01%)
Volume: 228.7 K
4:00PM ET 7/01/2022
 
 

Avalon Globocare Corp ( NASDAQ )

Price: $0.47
Change: -0.008 (1.68%)
Volume: 27.2 K
3:57PM ET 7/01/2022
 

Read more news Recent News

Chemomab Therapeutics Secures US Patent for Liver Disease Therapy
7:55AM ET 6/28/2022 MT Newswires

Chemomab Therapeutics (CMMB) said Tuesday it secured a US patent for its CM-101 monoclonal antibody. The patent covers the use of CM-101 and...

-- Earnings Flash (CMMB) CHEMOMAB THERAPEUTICS Reports Q1 Loss $-0.02, vs. Street Est of $-0.17
6:02AM ET 5/12/2022 MT Newswires

...

--Oppenheimer Adjusts Chemomab Therapeutics' Price Target to $20 From $30, Maintains Outperform Rating
9:26AM ET 3/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (CMMB) CHEMOMAB THERAPEUTICS Posts Q4 Loss $-0.02, vs. Street Est of $-0.10
6:00AM ET 3/09/2022 MT Newswires

...

Company Profile

Business Description
Number of Employees19
Recent SEC Filing06/21/20228-K

Company Highlights

Price Open$3.71
Previous Close$3.70
52 Week Range$2.53 - 20.96
Market Capitalization$37.9 M
Shares Outstanding11.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/12/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.41
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-25.27%

Analyst Ratings as of 12/06/2021

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset